Traws Pharma, Inc. · NASDAQ:TRAW
Ikarian Capital, LLC reported a 9.99% stake in Traws Pharma, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Ikarian Capital, LLC reported a 9.99% stake in Traws Pharma, Inc., 812,524 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 812,524
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Ikarian Capital, LLC | 9.99% | 812,524 |
| Neil Shahrestani | 9.99% | 812,524 |
Source
Related
- Traws Pharma, Inc.
- Ikarian Capital, LLC
- Traws Pharma, Inc. shareholders
- Schedule 13G/A · Ikarian Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Ikarian Capital, LLC · May 15, 2025
- Schedule 13G · Ikarian Capital, LLC · Feb 14, 2025
- Schedule 13G · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Aug 14, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13G/A · Perceptive Advisors LLC · May 15, 2026
- Schedule 13G/A · Squadron Capital Management LLC · May 15, 2026